Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced that it has achieved $2 million in milestone payments from the Juvenile Diabetes Research Foundation (JDRF) for progress made on a Phase II clinical trial evaluating Prochymal, a mesenchymal stem cell (MSC) therapy, for patients recently diagnosed with type 1 diabetes. The payments were triggered when Osiris accomplished certain clinical […]
Herbal-Review.com
Independent honest reviews of most effective natural herbal supplements
Osiris Therapeutics Announces 2 Million Dollars Milestone Payment For Clinical Progress Of A Stem Cell Therapy For Type 1 Diabetes
[link]
The URI to TrackBack this entry is: http://herbal-review.com/2008/06/28/osiris-therapeutics-announces-2-million-dollars-milestone-payment-for-clinical-progress-of-a-stem-cell-therapy-for-type-1-diabetes/trackback/
Leave a Reply
Please healthy :)
You must be logged in to post a comment.
|No results yet!
